Education
About Us
Working with TipRanks
Follow Us
Solventum Corporation (SOLV)
NYSE:SOLV
SOLV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$60.70 - $85.92
Previous CloseN/A
Volume531.14K
Average Volume (3M)1.20M
Market Cap
$12.37B
Enterprise Value$20.61B
Total Cash (Recent Filing)$492.00M
Total Debt (Recent Filing)$7.82B
Price to Earnings (P/E)32.9
Beta0.64
Next Earnings
Nov 06, 2025EPS Estimate
1.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.69
Shares Outstanding173,387,800
10 Day Avg. Volume1,200,762
30 Day Avg. Volume1,202,379
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.67
Enterprise Value/Revenue2.46
Enterprise Value/Gross Profit4.51
Enterprise Value/Ebitda16.15
Forecast
1Y Price Target
$89.50Price Target Upside25.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
EarningsThe Purification & Filtration sale is expected to be EPS accretive, as debt paydown using deal-related proceeds would more than offset the 'lost' Purification & Filtration’s earnings contribution.
Financial PerformanceManagement’s recent guidance update indicates higher 2025 numbers in line with deal-related EPS accretion.
Bears Say
Financial TargetsThere is limited upside to medium-term forecasts with back-end loaded growth.
MarginsRetaining the Drinking Water Filtration business is expected to reduce projected improvements to gross margin and operating margin.
SOLV FAQ
What was Solventum Corporation’s price range in the past 12 months?
Solventum Corporation lowest stock price was $60.70 and its highest was $85.92 in the past 12 months.
What is Solventum Corporation’s market cap?
Solventum Corporation’s market cap is $12.37B.
When is Solventum Corporation’s upcoming earnings report date?
Solventum Corporation’s upcoming earnings report date is Nov 06, 2025 which is in 37 days.
How were Solventum Corporation’s earnings last quarter?
Solventum Corporation released its earnings results on Aug 07, 2025. The company reported $1.69 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.24.
Is Solventum Corporation overvalued?
According to Wall Street analysts Solventum Corporation’s price is currently Undervalued.
Does Solventum Corporation pay dividends?
Solventum Corporation does not currently pay dividends.
What is Solventum Corporation’s EPS estimate?
Solventum Corporation’s EPS estimate is 1.42.
How many shares outstanding does Solventum Corporation have?
Solventum Corporation has 173,387,800 shares outstanding.
What happened to Solventum Corporation’s price movement after its last earnings report?
Solventum Corporation reported an EPS of $1.69 in its last earnings report, beating expectations of $1.45. Following the earnings report the stock price went up 2.001%.
Which hedge fund is a major shareholder of Solventum Corporation?
Currently, no hedge funds are holding shares in SOLV
Solventum Corporation Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$89.50 (25.40% Upside)
$89.50 (25.40% Upside)
Blogger Sentiment
Bullish
SOLV Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 3.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $646.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.5%
Last 30 Days ▲ 1.3%
Last 30 Days ▲ 1.3%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.80%
12-Months-Change
Fundamentals
Return on Equity
11.64%
Trailing 12-Months
Asset Growth
3.40%
Trailing 12-Months
Company Description
Solventum Corporation
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
SOLV Company Deck
SOLV Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong performance and strategic growth, with raised guidance and strategic partnerships highlighting the positive trajectory. However, challenges such as ERP implementation issues and tariff headwinds were noted.View all SOLV earnings summariesSOLV Stock 12 Month Forecast
Average Price Target
$89.50
▲(25.40% Upside)
Technical Analysis
DaVita
―
Fresenius Medical Care
―
Encompass Health
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
14.87% Insiders
17.77% Mutual Funds
24.69% Other Institutional Investors
22.76% Public Companies and
Individual Investors